- Original Articles Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis
- Michael H. Le, David M. Le, Thomas C. Baez, Hansen Dang, Vy H. Nguyen, KeeSeok Lee, Christopher D. Stave, Takanori Ito, Yuankai Wu, Yee Hui Yeo, Fanpu Ji, Ramsey Cheung, Mindie H. Nguyen
- Clin Mol Hepatol. 2024;30(2):235-246.
- Correspondences Correspondence on Letter regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
- Yee Hui Yeo, Ju Dong Yang
- Clin Mol Hepatol. 2024;30(1):124-125.
- Correspondence on Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
- Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng
- Clin Mol Hepatol. 2023;29(3):823-824.
- Correspondence on Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”
- Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng
- Clin Mol Hepatol. 2023;29(3):821-822.
- Original Articles Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
- Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo
- Clin Mol Hepatol. 2023;29(3):721-732.
- Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
- Michael H. Le, Yee Hui Yeo, Biyao Zou, Scott Barnet, Linda Henry, Ramsey Cheung, Mindie H. Nguyen
- Clin Mol Hepatol. 2022;28(4):841-850.